Unknown

Dataset Information

0

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors.


ABSTRACT: Despite the remarkable success of chimeric antigen receptor (CAR)-T cells against hematologic malignancies, severe off-tumor effects have constrained their use against solid tumors. Recently, CAR-engineered natural killer (NK) cells have emerged as an effective and safe alternative. Here, we demonstrate that HER2 CAR-expression in NK cells from healthy donors and patients with breast cancer potently enhances their anti-tumor functions against various HER2-expressing cancer cells, regardless of MHC class I expression. Moreover, HER2 CAR-NK cells exert higher cytotoxicity than donor-matched HER2 CAR-T cells against tumor targets. Importantly, unlike CAR-T cells, HER2 CAR-NK cells do not elicit enhanced cytotoxicity or inflammatory cytokine production against non-malignant human lung epithelial cells with basal HER2 expression. Further, HER2 CAR-NK cells maintain high cytotoxic function in the presence of immunosuppressive factors enriched in solid tumors. These results show that CAR-NK cells may be a highly potent and safe source of immunotherapy in the context of solid tumors.

SUBMITTER: Portillo AL 

PROVIDER: S-EPMC8193615 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4050065 | biostudies-literature
| S-EPMC8197981 | biostudies-literature
| S-EPMC10814835 | biostudies-literature
| S-EPMC10755030 | biostudies-literature
| S-EPMC9231490 | biostudies-literature
| S-EPMC7375514 | biostudies-literature
| S-EPMC6985149 | biostudies-literature
| S-EPMC7178328 | biostudies-literature
| S-EPMC8093220 | biostudies-literature
2024-08-22 | GSE275242 | GEO